Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities:: a safety and feasibility study

被引:193
作者
Vermeer, F
Ophuis, AJMO
van der Berg, EJ
Brunninkhuis, LG
Werter, CJ
Boehmer, AG
Lousberg, AH
Dassen, WR
Bär, FW
机构
[1] Univ Hosp, Dept Cardiol, NL-6202 AZ Maastricht, Netherlands
[2] Hosp De Wever & Gregorius, Brunssum Heerlen, Netherlands
[3] Maasland Hosp, Sittard, Netherlands
[4] Laurentius Hosp, Roermond, Netherlands
[5] St Jozef Hosp, Kerkrade, Netherlands
关键词
myocardial infarction; percutaneous transluminal coronary angioplasty; primary PTCA; rescue PTCA; reperfusion;
D O I
10.1136/hrt.82.4.426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To assess the safety and feasibility of acute transport followed by rescue percutaneous transluminal coronary angioplasty (PTCA) or primary PTCA in patients with acute myocardial infarction initially admitted to a hospital without PTCA facilities. Design-In a multicentre randomised open trial, three regimens of treatment of acute large myocardial infarction were compared for patients admitted to hospitals without angioplasty facilities: thrombolytic treatment with alteplase (75 patients), alteplase followed by transfer to the PTCA centre and (if indicated) rescue PTCA (74 patients), or transfer for primary PTCA (75 patients). Results-Between 1995 and 1997 224 patients were included. Baseline characteristics were distributed evenly. Transport to the PTCA centre was without severe complications in all patients. Mean (SD) delay from onset of symptoms to randomisation was 130 (75) minutes and from randomisation to angiography 90 (25) minutes. Death or recurrent infarction within 42 days occurred in 12 patients in the thrombolysis group, in 10 patients in the rescue PTCA group, and in six patients in the primary PTCA group. These differences were not significant. Conclusions-Acute transfer for rescue PTCA or primary PTCA in patients with extensive myocardial infarction is feasible and safe. Efficacy of rescue PTCA or primary PTCA in this setting will have to be tested in larger series before this approach can be implemented as "routine treatment" for patients with extensive myocardial infarction.
引用
收藏
页码:426 / 431
页数:6
相关论文
共 29 条
  • [1] FATE OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WITH PATENCY OF THE INFARCT-RELATED VESSEL ACHIEVED WITH SUCCESSFUL THROMBOLYSIS VERSUS RESCUE ANGIOPLASTY
    ABBOTTSMITH, CW
    TOPOL, EJ
    GEORGE, BS
    STACK, RS
    KEREIAKES, DJ
    CANDELA, RJ
    ANDERSON, LC
    HARRELSONWOODLIEF, SL
    CALIFF, RM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (04) : 770 - 778
  • [2] [Anonymous], 1989, NEW ENGL J MED, V320, P618
  • [3] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
    APPLEBY, P
    BAIGENT, C
    COLLINS, R
    FLATHER, M
    PARISH, S
    PETO, R
    BELL, P
    HALLS, H
    MEAD, G
    DIAZ, R
    PAOLASSO, E
    PAVIOTTI, C
    ROMERO, G
    CAMPBELL, T
    OROURKE, MF
    THOMPSON, P
    LESAFFRE, E
    VANDEWERF, F
    VERSTRAETE, M
    ARMSTRONG, PW
    CAIRNS, JA
    MORAN, C
    TURPIE, AG
    YUSUF, S
    GRANDE, P
    HEIKKILA, J
    KALA, R
    BASSAND, JP
    BOISSEL, JP
    BROCHIER, M
    LEIZOROVICZ, A
    BRUGGEMANN, T
    KARSCH, KR
    KASPER, W
    LAMMERTS, D
    NEUHAUS, KL
    MEYER, J
    SCHRODER, R
    VONESSEN, R
    SARAN, RK
    ARDISSINO, D
    BONADUCE, D
    BRUNELLI, C
    CERNIGLIARO, C
    FORESTI, A
    FRANZOSI, MG
    GUIDUCCI, D
    MAGGIONI, A
    MAGNANI, B
    MATTIOLI, G
    [J]. LANCET, 1994, 343 (8893) : 311 - 322
  • [4] Rescue PTCA following failed thrombolysis and primary PTCA: A retrospective study of angiographic and clinical outcome
    Bär F.W.
    Ophnis T.J.O.
    Frederiks J.
    De Swart H.B.
    Van Ommen V.G.
    De Zwaan C.
    Vermeer F.
    Gorgels A.P.
    Wellens H.J.
    [J]. Journal of Thrombosis and Thrombolysis, 1997, 4 (2) : 281 - 288
  • [5] Bar FW, 1997, AM J CARDIOL, V79, P727
  • [6] Betriu A, 1997, NEW ENGL J MED, V336, P1621
  • [7] EVALUATION OF COMBINATION THROMBOLYTIC THERAPY AND TIMING OF CARDIAC-CATHETERIZATION IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION PHASE-5 RANDOMIZED TRIAL
    CALIFF, RM
    TOPOL, EJ
    STACK, RS
    ELLIS, SG
    GEORGE, BS
    KEREIAKES, DJ
    SAMAHA, JK
    WORLEY, SJ
    ANDERSON, JL
    HARRELSONWOODLIEF, L
    WALL, TC
    PHILLIPS, HR
    ABBOTTSMITH, CW
    CANDELA, RJ
    FLANAGAN, WH
    SASAHARA, AA
    MANTELL, SJ
    LEE, KL
    [J]. CIRCULATION, 1991, 83 (05) : 1543 - 1556
  • [8] CHARACTERISTICS AND OUTCOME OF PATIENTS IN WHOM REPERFUSION WITH INTRAVENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR FAILS - RESULTS OF THE THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION (TAMI) I-TRIAL
    CALIFF, RM
    TOPOL, EJ
    GEORGE, BS
    BOSWICK, JM
    LEE, KL
    STUMP, D
    DILLON, J
    ABBOTTSMITH, C
    CANDELA, RJ
    KEREIAKES, DJ
    ONEILL, WW
    STACK, RS
    [J]. CIRCULATION, 1988, 77 (05) : 1090 - 1099
  • [9] INTRACRANIAL HEMORRHAGE IN ASSOCIATION WITH THROMBOLYTIC THERAPY - INCIDENCE AND CLINICAL PREDICTIVE FACTORS
    DEJAEGERE, PP
    ARNOLD, AA
    BALK, AH
    SIMOONS, ML
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (02) : 289 - 294
  • [10] Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction -: A double-blind, randomized angiographic trial of lanoteplase versus alteplase
    den Heijer, P
    Vermeer, F
    Ambrosioni, E
    Sadowski, Z
    López-Sendón, JL
    von Essen, R
    Beaufils, P
    Thadani, U
    Adgey, J
    Pierard, L
    Brinker, J
    Davies, RF
    Smalling, RW
    Wallentin, L
    Caspi, A
    Pangerl, A
    Trickett, L
    Hauck, C
    Henry, D
    Chew, P
    [J]. CIRCULATION, 1998, 98 (20) : 2117 - 2125